A randomized multicenter trial of epirubicin, oxaliplatin, and capecitabine (EOC) plus panitumumab in advanced esophagogastric cancer (REAL3)

Autoria(s): Waddell, T.S.; Chau, I.; Barbachano, Y.; de Castro, D.G.; Wotherspoon, A.; Saffery, C.; Middleton, G.W.; Wadsley, J.; Ferry, D.R.; Mansoor, W.; Crosby, T.D.L.; Coxon, F.Y.; Smith, D.; Waters, J.S.; Iveson, T.; Falk, S.; Slater, S.; Okines, A.F.C.; Cunningham, D.
Data(s)

20/06/2012
Identificador

http://pure.qub.ac.uk/portal/en/publications/a-randomized-multicenter-trial-of-epirubicin-oxaliplatin-and-capecitabine-eoc-plus-panitumumab-in-advanced-esophagogastric-cancer-real3(af61abb1-5672-4f40-9670-57f31db49475).html
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Waddell , T S , Chau , I , Barbachano , Y , de Castro , D G , Wotherspoon , A , Saffery , C , Middleton , G W , Wadsley , J , Ferry , D R , Mansoor , W , Crosby , T D L , Coxon , F Y , Smith , D , Waters , J S , Iveson , T , Falk , S , Slater , S , Okines , A F C & Cunningham , D 2012 , ' A randomized multicenter trial of epirubicin, oxaliplatin, and capecitabine (EOC) plus panitumumab in advanced esophagogastric cancer (REAL3) ' .
Tipo

conferenceObject
Acesso ao item digital